← All trials
NCT00050180
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 22, 2002
- Primary completion
- Aug 24, 2007
- Completion date
- Aug 24, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 81
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- National Institutes of Health (NIH)Lead sponsor
- National Cancer Institute (NCI)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.